Annual Report 2024

Proposal of the Board of Directors for the appropriation of the available profit

in CHF

 

2024

 

2023

Profit / (loss) for the year

 

19’032’695

 

33’551’684

Unallocated profit carried forward from previous year

 

16’024’909

 

2’861’343

Total available profit

 

35’057’604

 

36’413’027

Ordinary dividend

 

–20’395’376

 

–20’388’118

Balance carried forward

 

14’662’228

 

16’024’909

 

 

 

 

 

Dividend distribution per share

 

 

 

 

Gross dividend

 

0.50

 

0.50

Withholding tax (35%)

 

–0.18

 

–0.18

Net dividend

 

0.32

 

0.32

The Board of Directors proposes the payment of a dividend of CHF 0.50 per share to the Annual General Meeting on April 23, 2025. The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries.